Thyroid Eye DiseaseConfirmed
FDA Approved Lumvoa for Thyroid Eye Disease
Viridian's Lumvoa gives thyroid eye disease patients another FDA-approved option, but the approval should not be framed as a cure or as proof it beats Tepezza.
Why now
The FDA decision changes the treatment-option landscape for thyroid eye disease and gives patients another approved drug to discuss with specialists.
- Overclaim risk
- medium
- Primary source
- Trade news
- Published
- Jun 30, 2026